Organization
MetroHealth, Rhematology Department, Cleveland, United States of America
1 abstract
Abstract
BASELINE CHARACTERISTICS AND TREATMENT RESPONSE TO IXEKIZUMAB CATEGORISED BY SEX IN RADIOGRAPHIC AND NON-RADIOGRAPHIC AXIAL SPONDYLARTHRITIS PATIENTS THROUGH 52 WEEKS: DATA FROM 3 PHASE III, RANDOMIZED, CONTROLLED TRIALSOrg: Amsterdam UMC, locatie VUmc, Department of Rheumatology, Amsterdam, Netherlands, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, United States of America, MetroHealth, Rhematology Department, Cleveland, United States of America,